FDA Updates Alert on Counterfeit Glucose Test Strips

Using the counterfeit products could produce inaccurate readings of blood glucose levels, prompting a patient to take too much or too little insulin, both of which can have serious health consequences. FDA also announced a collaboration with the Federal Trade Commission and Mexican and Canadian authorities in an effort to stop advertisements and sales of products misrepresented as cures or treatments for diabetes. Most of the products in question are dietary supplements.